United Therapeutics | UTHR - Beneficio Operativo





Beneficio Operativo Cambio Fecha
Amarin USD -2.26M 564K 2025-12
Ardelyx USD -32.79M 37.89M 2026-03
Baxter International USD 276M 210M 2026-06
Bayer EUR 3.53B 2.42B 2026-03
BioCryst Pharmaceuticals USD 260.38M 230.79M 2025-12
Biogen USD -243.8M 758.1M 2026-06
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
Emergent BioSolutions USD -218M 69.9M 2023-06
Gilead Sciences USD 2.68B 284M 2026-03
GlaxoSmithKline GBP 2.6B 312M 2026-06
Halozyme Therapeutics USD -61.77M 26.64M 2026-03
Insmed USD -200.28M 49.43M 2026-03
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
J&J USD 7.48B 860M 2026-06
Lexicon Pharmaceuticals USD -14.78M 2.59M 2025-12
Moderna USD -815M 573M 2026-06
Omeros USD -35.41M 23.75M 2024-09
Pfizer USD 4.99B 340M 2026-03
PTC Therapeutics USD 45.89M 127.51M 2026-03
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Sarepta Therapeutics USD 358.43M 768.52M 2026-03
Teva Pharmaceutical Industries USD 235M 523M 2026-06
United Therapeutics USD 325.8M 340.4M 2026-03
Vertex Pharmaceuticals USD 1.14B 124.5M 2026-03